Skip to content

VITROLIFE

Active Private limited companyfounded 2017active for 8 yearsZwaluwstraat 115A, 1840 LonderzeelKBO/BCE: BE 0685.675.182

Lifetime

8 annual accounts with figures on one time axis
peak of €1.7m in 2025
€1.7m▲ 37.1%
peak of €195,989 in 2024
€167,338▼ 14.6%
peak of €1.0m in 2025
€1.0m▲ 19.0%
€1.2m▼ 22.7%
peak of 5 FTE in 2025
5 FTE▲ 16.3%
Board7 names since 2017
1 director
Documentsfilings and deeds
06-08-20266 days late
2025abbreviated format
Gross margin from €1.2m to €1.7mStaff from 4.3 FTE to 5 FTE resigns as director 23-07Registered office moved within Londerzeel 15-04Equity from €880,450 to €1.0mDebts from €1.5m to €1.2m

Key points

from the 2025 annual accounts

Equity

€1.0m ▲ 19.0%

VITROLIFE has made a profit in every financial year since 2018.

Turnover

≈ €6.9m estimated

The abbreviated format states no turnover.

Staff

5 employees on 31-12-2025
202024112025

In 2025, 1 employee joined and 1 left.

Filings

8 annual accounts 6 late
AprilJune31 JulyOctober20202025

The 2019 accounts came in latest, 35 days after the end of the period.

Position in the sector

€1.7m

Higher gross margin than 91% of companies in wholesale trade. Sector median €273,338 · 10,765 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as VITROLIFE has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for VITROLIFE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 08-04-2025
Auditor,
  • 181 sharesdeed of 08-12-2017
  • 5 sharesdeed of 08-12-2017
Board & ownership

Recent changes

resigns as director General meeting of 02-06-2025 · Gazette deed
Registered office moved within Londerzeel The registered office moved from Zwaluwstraat 113, 1840 Londerzeel to Zwaluwstraat 115A, 1840 Londerzeel · changes role from manager to niet statutaire bestuurder van bv vitrolife · resigns as manager · General meeting of 08-04-2025 · Gazette deed
resigns as director General meeting of 06-03-2023 · Gazette deed
reappointed as statutory auditor acts as permanent representative · General meeting of 15-06-2021 · Gazette deed
All 23 events

Comparable companies

same main activity, similar in size and age
Company
VITROLIFE Londerzeel €2.2m €1.7m 46.6% 5
Ascensia Diabetes Care Belgium Machelen (Brab.) €2.6m €1.5m 62.6% 8.3
MicroPort CRM Saint-Josse-ten-Noode €1.3m €1.7m 32.5% 5.8
AAGATO MEDICAL Ghent €3.9m €1.4m 28.6% 5.8
ASP BELGIUM Saint-Josse-ten-Noode €2.9m €0.8m 77.6% 5
PAMSANTE BENELUX Brussels €2.4m €1.1m 34.9% 4
LIFEXA Schaerbeek €2.9m €0.8m 49.5% 4.8

These companies have the same main activity as VITROLIFE: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.3m and €3.9m, founded between 2015 and 2020.

Official details

Source: KBO
Status
Active since 06-12-2017Normal situation
Registered office
14 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 19 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2025
Establishment unit
2.270.862.1491840 Londerzeel, since 06-12-2017
Financial year end
31 December
Peppol
Reachable since 20-11-2020
Company details

Annual accounts 2025

€2.2m▼ 5.6%
Employeeson 31-12-2025
5=
Filing
Filed on 06-08-2026
Financials

Insights on VITROLIFE

VITROLIFE files the abbreviated format. That format states no turnover. The gross margin rose from €555,777 in 2018 to €1.7m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about VITROLIFE

What is the company number of VITROLIFE?
The company number of VITROLIFE is 0685.675.182. The VAT number is the same number with BE in front: BE 0685.675.182.
Where is VITROLIFE based?
The registered office is at Zwaluwstraat 115A, 1840 Londerzeel.Company details
What does VITROLIFE do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of VITROLIFE?
VITROLIFE is a private limited company (BV).
When was VITROLIFE founded?
VITROLIFE was founded on 06-12-2017.
Is VITROLIFE still active?
Yes, VITROLIFE is an active enterprise in the KBO register.
How many employees does VITROLIFE have?
VITROLIFE had an average of 5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does VITROLIFE fall under?
In its 2025 annual accounts, VITROLIFE states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of VITROLIFE?
The turnover in financial year 2025 is ≈ €6.9m. This figure is estimated from the gross margin of €1.7m and 96 comparable companies (NACE 46). It probably lies between €4.2m and €12.0m.
Is VITROLIFE profitable?
In financial year 2025, VITROLIFE made a profit of €167,338.
Where can I find the annual accounts of VITROLIFE?
VITROLIFE filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VITROLIFE due?
VITROLIFE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.